Prosthetic valve endocarditis: Literally a growing concern following transcatheter aortic valve replacement

Andrew M. Goldsweig, Suzanne J. Baron

Research output: Contribution to journalEditorialpeer-review

Abstract

Prosthetic valve endocarditis (PVE) following transcatheter aortic valve replacement (TAVR) in low surgical risk patients is uncommon, occurring in 11 of 396 patients (2.8%) in the study by Medranda et al., but associated with high morbidity (6 of 11 with embolic strokes [55%]) and mortality (2 of 11 [18%]). As TAVR volumes increase, especially in low surgical risk patients, whose long-term outcomes are generally excellent, PVE will become an increasingly important concern. Future research is needed to identify optimal strategies for prevention, diagnosis, and treatment of PVE associated with TAVR.

Original languageEnglish (US)
Pages (from-to)904-905
Number of pages2
JournalCatheterization and Cardiovascular Interventions
Volume99
Issue number3
DOIs
StatePublished - Feb 15 2022

Keywords

  • AVD – aortic valve disease
  • AVDP – aortic valve disease percutaneous intervention
  • ENDO – endocarditis
  • RISK– risk stratification
  • TVI – transcatheter valve implantation

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Prosthetic valve endocarditis: Literally a growing concern following transcatheter aortic valve replacement'. Together they form a unique fingerprint.

Cite this